Financhill
Back

Vertex Pharmaceuticals Vs. Novo Nordisk AS Industry Stock Comparison

Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
$397.10
Seasonality Move:
6.89%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $397.27. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $397.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.99 Sell
Relative Strength Index (14 RSI): 24.09 Sell
Chaikin Money Flow: 2740027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (437.81 - 475.91) Sell
Bollinger Bands (100): (455.22 - 489.42) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 446.86 Sell
20-day SMA: 456.96 Sell
50-day SMA: 470.34 Sell
200-day SMA: 457.21 Sell
8-day EMA: 436.6 Sell
20-day EMA: 452.97 Sell
50-day EMA: 463.97 Sell
200-day EMA: 453.34 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.29 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):